This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Peripheral Artery Disease
and you are
between 50 and 130
years old
Phase
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The purpose of this study is to compare the effects of ticagrelor and clopidogrel in patients with Peripheral Artery Disease.

Provided treatments

  • Drug: Ticagrelor
  • Drug: Clopidogrel
Tris trial is registered with FDA with number: NCT01732822. The sponsor of the trial is AstraZeneca and it is looking for 13885 volunteers for the current phase.
Official trial title:
A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)